InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+7.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Nichtberger Steven, 董事长兼首席执行官. Insider active across 1 company, notably Cabaletta Bio, Inc.. Cumulatively, 4 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €239k. History available since 31 January 2022. The latest transaction was filed on 21 January 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Nichtberger Steven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
45,000 股@ US$2.239530.2% 占其流量Common StockSEC:0001193125-26-018318:0
标准退出：2026年4月21日 (T+90)
8,127 股@ US$1.24924.3% 占其流量Common StockSEC:0000899243-22-033850:0
标准退出：2023年1月17日 (T+90)
141,873 股@ US$0.993958.6% 占其流量Common StockSEC:0000899243-22-033779:0
标准退出：2023年1月16日 (T+90)
50,000 股@ US$1.0115.9% 占其流量Common StockSEC:0000899243-22-004158:0
4 条申报中的 4 条
About Nichtberger Steven
Nichtberger Steven serves as President and Chief Executive Officer of Cabaletta Bio, Inc. In this role, he leads the company's operations and develops strategies to achieve growth objectives. His expertise in the biopharmaceutical field is essential for Cabaletta, which focuses on developing innovative treatments. Nichtberger is committed to improving patient health through advanced therapeutic solutions.
